# Docetaxel

NDC: 43066-006
Generic name: docetaxel
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180219

FDA application: NDA201525

## Active ingredients

- DOCETAXEL: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-006"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-006
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e0f06bd-d190-45da-be8b-062e8de01970